Physician

Alyson Beth Simpson, MD

According to 2025 Medicare claims, Alyson Simpson, MD (NPI: 1538288162) practices allergy/immunology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is ABS MEDICINE LLC (NPI: 1730587486; TIN: 47-2521078) and primary practice location at 19446-5242.

Simpson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 36,315 HCPCS/CPT codes, and received $931,694 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,313 prescription claims across 265 beneficiaries totaling $522,114 in drug costs, led by Tezspire (Tezepelumab-Ekko). DME data shows 189 claims. Open Payments data shows 81 records totaling $1,670. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $21,206 to $931,694. Similarly, Part D prescription costs have risen steadily, from $26,469 to $522,114. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$466K$932K2015 Medicare payment: $21,206 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $42,336 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $39,346 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $38,124 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $115,210 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $238,715 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $360,744 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $672,738 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $792,940 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $931,694 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015601,685$21,206
20161113,505$42,336
2017703,642$39,346
2018693,048$38,124
20191217,094$115,210
20201449,602$238,715
202116613,754$360,744
202220523,354$672,738
202319930,006$792,940
202422436,315$931,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$699K$1.4M2015 Drug cost: $26,469 (USD; Tot_Drug_Cst)2016 Drug cost: $39,507 (USD; Tot_Drug_Cst)2017 Drug cost: $32,420 (USD; Tot_Drug_Cst)2018 Drug cost: $105,366 (USD; Tot_Drug_Cst)2019 Drug cost: $116,643 (USD; Tot_Drug_Cst)2020 Drug cost: $377,486 (USD; Tot_Drug_Cst)2021 Drug cost: $1,398,779 (USD; Tot_Drug_Cst)2022 Drug cost: $445,405 (USD; Tot_Drug_Cst)2023 Drug cost: $428,288 (USD; Tot_Drug_Cst)2024 Drug cost: $522,114 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201557131$26,469
201672228$39,507
201770250$32,420
201878355$105,366
2019115432$116,643
2020144605$377,486
2021184847$1,398,779
20222361,258$445,405
20232201,233$428,288
20242651,313$522,114

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$135K$271K2015 Medicare payment: $105 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $578 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $81,106 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $98,603 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $270,826 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$105
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R11$578
2021N/RN/RN/R
2022N/R62$81,106
2023N/R79$98,603
2024N/R189$270,826

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more103103$134
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more99172$102
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle51727$57
95117Professional service for multiple injections of allergen46672$10
95004Test for allergy using allergenic extract402,410$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TezspireTezepelumab-Ekko26728$106,151
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5011308$92,748
Dupixent PenDupilumab11308$40,950
XolairOmalizumab12336$32,907
Zileuton ErZileuton13390$26,118

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R36$138,014
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R20$59,702
J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R13$59,155
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R33$10,878
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R35$2,496

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.81$1,670AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alyson Beth Simpson, MD?

Tedicare shows public-source Medicare data for Alyson Beth Simpson, MD (NPI 1538288162), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alyson Beth Simpson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alyson Beth Simpson, MD?

Alyson Beth Simpson, MD is linked to ABS MEDICINE LLC (billing NPI 1730587486) in the available physician profile data.

Does Alyson Beth Simpson, MD have Open Payments data?

Alyson Beth Simpson, MD has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.